TARS logo

Tarsus Pharmaceuticals (TARS) Retained earnings

annual retained earnings:

-$360.21M-$115.55M(-47.23%)
December 31, 2024

Summary

  • As of today (July 1, 2025), TARS annual retained earnings is -$360.21 million, with the most recent change of -$115.55 million (-47.23%) on December 31, 2024.
  • During the last 3 years, TARS annual retained earnings has fallen by -$313.54 million (-671.79%).
  • TARS annual retained earnings is now -26308.36% below its all-time high of -$1.36 million, reached on December 31, 2018.

Performance

TARS Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

quarterly retained earnings:

-$385.33M-$25.12M(-6.97%)
March 31, 2025

Summary

  • As of today (July 1, 2025), TARS quarterly retained earnings is -$385.33 million, with the most recent change of -$25.12 million (-6.97%) on March 31, 2025.
  • Over the past year, TARS quarterly retained earnings has dropped by -$104.94 million (-37.43%).
  • TARS quarterly retained earnings is now -6285.98% below its all-time high of -$6.03 million, reached on December 31, 2019.

Performance

TARS quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TARS Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-47.2%-37.4%
3 y3 years-671.8%-475.9%
5 y5 years-5869.7%-

TARS Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-671.8%at low-430.4%at low
5 y5-year-5869.7%at low-3327.9%at low
alltimeall time<-9999.0%at low-6286.0%at low

TARS Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$385.33M(+7.0%)
Dec 2024
-$360.21M(+47.2%)
-$360.21M(+6.9%)
Sep 2024
-
-$337.10M(+7.5%)
Jun 2024
-
-$313.68M(+11.9%)
Mar 2024
-
-$280.39M(+14.6%)
Dec 2023
-$244.66M(+124.9%)
-$244.66M(+20.7%)
Sep 2023
-
-$202.75M(+23.9%)
Jun 2023
-
-$163.61M(+23.8%)
Mar 2023
-
-$132.18M(+21.5%)
Dec 2022
-$108.76M
-$108.76M(+14.3%)
Sep 2022
-
-$95.16M(+31.0%)
DateAnnualQuarterly
Jun 2022
-
-$72.65M(+8.6%)
Mar 2022
-
-$66.91M(+43.4%)
Dec 2021
-$46.67M(+42.1%)
-$46.67M(+46.7%)
Sep 2021
-
-$31.82M(+97.4%)
Jun 2021
-
-$16.12M(-28.2%)
Mar 2021
-
-$22.47M(-31.6%)
Dec 2020
-$32.84M(+444.3%)
-$32.84M(+53.6%)
Sep 2020
-
-$21.38M(+90.2%)
Jun 2020
-
-$11.24M(+86.3%)
Dec 2019
-$6.03M(+342.4%)
-$6.03M
Dec 2018
-$1.36M
-

FAQ

  • What is Tarsus Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual retained earnings year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly retained earnings year-on-year change?

What is Tarsus Pharmaceuticals annual retained earnings?

The current annual retained earnings of TARS is -$360.21M

What is the all time high annual retained earnings for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual retained earnings is -$1.36M

What is Tarsus Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, TARS annual retained earnings has changed by -$115.55M (-47.23%)

What is Tarsus Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of TARS is -$385.33M

What is the all time high quarterly retained earnings for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly retained earnings is -$6.03M

What is Tarsus Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, TARS quarterly retained earnings has changed by -$104.94M (-37.43%)
On this page